Wearables such as smartwatches are already an integral part of our everyday lives. They track our pulse, the number of steps we take and our sleep rhythm. Glucose measurement using CGM systems is currently considered the gold standard. Can Dincer, Professor of Sensors and Wearables for Healthcare at the Technical University of Munich (TUM), explains in an interview in which direction the development can still go in the future.
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- An emerging interface with clinical relevance
Lung cancer and neuroscience
- Acute leukemia: Disease management
Priorities from the perspective of patients and family caregivers
- Bronchodilators for asthma
The early bird … gasps for air
- Chronic kidney disease (CKD)
Triage of high-risk patients – Update 2025
- AAD Annual Meeting: Review
HS and acne – what’s new?
- New perspectives for the optimization of cancer immunotherapy
Nanoparticle-mediated intratumoral gene editing of PD-L1 and galectin-9
- Past, present and future
Biomarkers in schizophrenia
- From genome profiles to targeted therapies